Value proposition

Primary & iPSC in vitro models of human physiology for drug discovery, to accurately predict in vivo outcomes.

In vitro tissue models validated to mimic in vivo human physiology to improve confidence in drug discovery

We are experts in building and applying complex models of human tissues for drug discovery.
We are cell biologists, tissue physiologists and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.

We carry out in vitro studies or provide products that enable customers to generate data on efficacy, safety and transport to de-risk discovery and development.

Our experts collaborate with customers to design studies to provide data that answer critical questions for pre-clinical drug development. We run the study, provide and interpret the data, or we can supply products and support you in your in-house studies.

Induced pluripotent stem cells (iPSCs), Cellular reprogramming and differentiation, Supply of iPSC derived cells for drug development, Sourcing samples for human disease cell lines, Nephrotoxity Testing, ADMET, DIKI, Drug Transport Studies, RPE, Retinal Epithelia, Lung Epithelia, Proximal Tubule Model, Stem Cell Models, Drug Induced Kidney Injury (DIKI), Disease Modelling, Retinal Epithelial Model, Toxicity, Retina, Kidney, and Lung